Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for dna topoisomerases, type ii (compound)
Most Correlated Studies
- Retinal pigment epithelium hTERT RPE-1 cells treated with merbarone
- Topoisomerase II RNAi knockdown in S2 cells
- DNA topoisomerase deficiencies affects on gene expression
- Acute myeloid leukemia cells treated with cell-specific IC50 concentrations of etoposide
- Livers, lungs, and hearts of FVB nude mice treated with etoposide or doxorubicin
Most Relevant Literature
- The rate of opening and closing of the DNA gate for topoisomerase II.
- Insight into eukaryotic topoisomerase II-inhibiting fused heterocyclic compounds in human cancer cel…
- Amsacrine as a topoisomerase II poison: importance of drug-DNA interactions.
- Topoisomerase II-mediated DNA cleavage and mutagenesis activated by nitric oxide underlie the inflam…
- Clinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 l…
Most Relevant Clinical Trials
- Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubic…
- Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast …
- Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or t…
- DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acu…
- Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCL…
